European trial on reduction of cardiac events with perindopril in stable coronary artery disease - EUROPA

Description:

The goal of the EUROPA trial was to evaluate the effect of treatment with the angiotensin-converting enzyme (ACE) inhibitor perindopril compared with placebo on cardiovascular (CV) events in patients with stable coronary artery disease (CAD).